202 related articles for article (PubMed ID: 28007901)
1. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype.
Quek H; Luff J; Cheung K; Kozlov S; Gatei M; Lee CS; Bellingham MC; Noakes PG; Lim YC; Barnett NL; Dingwall S; Wolvetang E; Mashimo T; Roberts TL; Lavin MF
Hum Mol Genet; 2017 Jan; 26(1):109-123. PubMed ID: 28007901
[TBL] [Abstract][Full Text] [Related]
2. Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA damage.
Quek H; Luff J; Cheung K; Kozlov S; Gatei M; Lee CS; Bellingham MC; Noakes PG; Lim YC; Barnett NL; Dingwall S; Wolvetang E; Mashimo T; Roberts TL; Lavin MF
J Leukoc Biol; 2017 Apr; 101(4):927-947. PubMed ID: 27895165
[TBL] [Abstract][Full Text] [Related]
3. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
Lavin MF
DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.
Song X; Ma F; Herrup K
J Neurosci; 2019 Aug; 39(32):6378-6394. PubMed ID: 31189575
[TBL] [Abstract][Full Text] [Related]
5. Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction.
Bourseguin J; Cheng W; Talbot E; Hardy L; Lai J; Jeffries AM; Lodato MA; Lee EA; Khoronenkova SV
Nucleic Acids Res; 2022 Mar; 50(5):2700-2718. PubMed ID: 35212385
[TBL] [Abstract][Full Text] [Related]
6. ATM-deficiency-induced microglial activation promotes neurodegeneration in ataxia-telangiectasia.
Lai J; Demirbas D; Kim J; Jeffries AM; Tolles A; Park J; Chittenden TW; Buckley PG; Yu TW; Lodato MA; Lee EA
Cell Rep; 2024 Jan; 43(1):113622. PubMed ID: 38159274
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice.
Hui CW; Song X; Ma F; Shen X; Herrup K
J Neuroinflammation; 2018 Nov; 15(1):308. PubMed ID: 30400801
[TBL] [Abstract][Full Text] [Related]
8. NAD
Fang EF; Kassahun H; Croteau DL; Scheibye-Knudsen M; Marosi K; Lu H; Shamanna RA; Kalyanasundaram S; Bollineni RC; Wilson MA; Iser WB; Wollman BN; Morevati M; Li J; Kerr JS; Lu Q; Waltz TB; Tian J; Sinclair DA; Mattson MP; Nilsen H; Bohr VA
Cell Metab; 2016 Oct; 24(4):566-581. PubMed ID: 27732836
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of cerebellar microglia in Ataxia-telangiectasia.
Levi H; Bar E; Cohen-Adiv S; Sweitat S; Kanner S; Galron R; Mitiagin Y; Barzilai A
Glia; 2022 Mar; 70(3):536-557. PubMed ID: 34854502
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia.
Li J; Hart RP; Mallimo EM; Swerdel MR; Kusnecov AW; Herrup K
Nat Neurosci; 2013 Dec; 16(12):1745-53. PubMed ID: 24162653
[TBL] [Abstract][Full Text] [Related]
11. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia.
Quick KL; Dugan LL
Ann Neurol; 2001 May; 49(5):627-35. PubMed ID: 11357953
[TBL] [Abstract][Full Text] [Related]
12. Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease.
Saunders RA; Michniacki TF; Hames C; Moale HA; Wilke C; Kuo ME; Nguyen J; Hartlerode AJ; Moore BB; Sekiguchi JM
Sci Rep; 2021 Feb; 11(1):4268. PubMed ID: 33608602
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia mutated is essential during adult neurogenesis.
Allen DM; van Praag H; Ray J; Weaver Z; Winrow CJ; Carter TA; Braquet R; Harrington E; Ried T; Brown KD; Gage FH; Barlow C
Genes Dev; 2001 Mar; 15(5):554-66. PubMed ID: 11238376
[TBL] [Abstract][Full Text] [Related]
14. ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration.
Carlessi L; Fusar Poli E; De Filippis L; Delia D
DNA Repair (Amst); 2013 Aug; 12(8):605-11. PubMed ID: 23707302
[TBL] [Abstract][Full Text] [Related]
15. Microglial Self-Recognition STINGs in A-T Neurodegeneration.
Ferro A; Sheeler C; Cvetanovic M
Trends Neurosci; 2019 Nov; 42(11):753-755. PubMed ID: 31623867
[TBL] [Abstract][Full Text] [Related]
16. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of Ataxia-telangiectasia mutated gene in miniature pigs by somatic cell nuclear transfer.
Kim YJ; Ahn KS; Kim M; Kim MJ; Park SM; Ryu J; Ahn JS; Heo SY; Kang JH; Choi YJ; Choi SJ; Shim H
Biochem Biophys Res Commun; 2014 Oct; 452(4):901-5. PubMed ID: 25193705
[TBL] [Abstract][Full Text] [Related]
18. ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage.
Chan SF; Sances S; Brill LM; Okamoto S; Zaidi R; McKercher SR; Akhtar MW; Nakanishi N; Lipton SA
J Neurosci; 2014 Mar; 34(13):4640-53. PubMed ID: 24672010
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia.
Nissenkorn A; Ben-Zeev B
Handb Clin Neurol; 2015; 132():199-214. PubMed ID: 26564081
[TBL] [Abstract][Full Text] [Related]
20. A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.
Beraldi R; Chan CH; Rogers CS; Kovács AD; Meyerholz DK; Trantzas C; Lambertz AM; Darbro BW; Weber KL; White KA; Rheeden RV; Kruer MC; Dacken BA; Wang XJ; Davis BT; Rohret JA; Struzynski JT; Rohret FA; Weimer JM; Pearce DA
Hum Mol Genet; 2015 Nov; 24(22):6473-84. PubMed ID: 26374845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
